Startseite>>Lipids>> Fatty Esters/Ethers>>Eicosapentaenoic Acid methyl ester

Eicosapentaenoic Acid methyl ester (Synonyms: all-cis-5,8,11,14,17-EPA methyl ester, C20:5(5Z,8Z,11Z,14Z,17Z) methyl ester, C20:5(cis-5,8,11,14,17) methyl ester, EPA methyl ester)

Katalog-Nr.GC41395

EicosapentaensÄuremethylester ist ein Abbauprodukt eines Monogalactosyldiacylglycerols (einer Antikrebsverbindung, die Apoptose induziert).

Products are for research use only. Not for human use. We do not sell to patients.

Eicosapentaenoic Acid methyl ester Chemische Struktur

Cas No.: 2734-47-6

Größe Preis Lagerbestand Menge
10mg
38,00 $
Auf Lager
50mg
123,00 $
Auf Lager
100mg
189,00 $
Auf Lager
500mg
851,00 $
Auf Lager

Tel:(909) 407-4943 Email: sales@glpbio.com

Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Eicosapentaenoic acid (EPA) is an ω-3 fatty acid which can have beneficial effects on vascular and immune physiology. Also, EPA serves as a precursor for resolvins, mediators that help resolve inflammatory processes. EPA methyl ester is a more lipid-soluble form of EPA. This compound may be more desirable than the free acid in certain formulations. In addition, the methyl ester form of EPA may serve as a prodrug, since it should facilitate uptake of EPA and then be hydrolyzed by esterases to generate the free acid after uptake into cells.

Bewertungen

Review for Eicosapentaenoic Acid methyl ester

Average Rating: 5 ★★★★★ (Based on Reviews and 16 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Eicosapentaenoic Acid methyl ester

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.